Study: PD-L1 may have Application in Obesity Treatment

Scientists may have found an added benefit to the programmed death-ligand 1 (PD-L1) protein beyond cancer immunotherapies after research demonstrated its ability to protect against obesity.

In a study published in Science Translational Medicine, researchers saw that PD-L1 on dendritic cells could control adaptive immune responses within adipose tissues to limit diet-induced obesity.